Celladon's Grant

Celladon raised a round of funding on June 24, 2009. Investors include Qualifying Therapeutic Discovery Project.

Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure. The company's products target the key enzyme deficiency in advanced heart failure, SERCA2a, which…

Articles about Celladon's Grant: